Deutsche Bank Ag\ Galmed Pharmaceuticals Ltd. Transaction History

Deutsche Bank Ag\

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$3.3 - $6.84 $15,275 - $31,662	-4,629 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$3.61 - $6.75 $16,548 - $30,942	4,584 Added 10186.67%	4,629 $26,000
Q3 2019 Nov 14, 2019	SELL	$4.62 - $7.11 $149,018 - $229,333	-32,255 Reduced 99.86%	45 $0
Q2 2019 Aug 14, 2019	SELL	$5.68 - $8.68 $2,840 - $4,340	-500 Reduced 1.52%	32,300 $237,000
Q1 2019 May 15, 2019	SELL	$7.27 - $9.07 $5,816 - $7,256	-800 Reduced 2.38%	32,800 $267,000
Q4 2018 Feb 14, 2019	BUY	$6.59 - $14.47 $221,424 - $486,192	33,600 New	33,600 $229,000
Q2 2018 Aug 14, 2018	SELL	$5.04 - $17.96 $360,788 - $1.29 Million	-71,585 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$5.12 - $11.77 $228,536 - $525,365	44,636 Added 165.63%	71,585 $398,000
Q4 2017 Feb 14, 2018	BUY	$6.78 - $9.32 $182,714 - $251,164	26,949	26,949 $246,000

Ticker GLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,088,400
Market Cap $71.8M
Description
Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or t...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.